{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:29:10Z","timestamp":1791473350801,"version":"4.3.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP25K12821"],"award-info":[{"award-number":["JP25K12821"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-34922-3","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T10:02:27Z","timestamp":1769421747000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Menin-MLL inhibitors as a new therapeutic target for middle ear cholesteatoma"],"prefix":"10.1038","volume":"16","author":[{"given":"Tomomi","family":"Yamamoto-Fukuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naotaro","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,26]]},"reference":[{"key":"34922_CR1","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/lary.24890","volume":"125","author":"CL Kuo","year":"2015","unstructured":"Kuo, C. L. Etiopathogenesis of acquired cholesteatoma: Prominent theories and recent advances in biomolecular research. Laryngoscope 125, 234\u2013240 (2015).","journal-title":"Laryngoscope"},{"key":"34922_CR2","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s10162-018-0662-z","volume":"19","author":"T Yamamoto-Fukuda","year":"2018","unstructured":"Yamamoto-Fukuda, T., Akiyama, N., Takahashi, M. & Kojima, H. Keratinocyte growth factor (KGF) modulates epidermal progenitor cell kinetics through activation of p63 in middle ear cholesteatoma. J. Assoc. Res. Otolaryngol. 19, 223\u2013241 (2018).","journal-title":"J. Assoc. Res. Otolaryngol."},{"key":"34922_CR3","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1080\/00016489950180801","volume":"119","author":"HO Kemppainen","year":"1999","unstructured":"Kemppainen, H. O. et al. Epidemiology and aetiology of middle ear cholesteatoma. Acta Otolaryngol. 119, 568\u2013572 (1999).","journal-title":"Acta Otolaryngol."},{"key":"34922_CR4","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/coa.14257","volume":"50","author":"E Wilson","year":"2025","unstructured":"Wilson, E. et al. Epidemiology of cholesteatoma in the UK Biobank. Clin. Otolaryngol. 50, 316\u2013329 (2025).","journal-title":"Clin. Otolaryngol."},{"key":"34922_CR5","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s12105-018-0915-5","volume":"12","author":"JT Castle","year":"2018","unstructured":"Castle, J. T. Cholesteatoma pearls: Practical points and update. Head Neck Pathol. 12, 419\u2013429 (2018).","journal-title":"Head Neck Pathol."},{"key":"34922_CR6","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1055\/s-0039-1697989","volume":"24","author":"PR M\u00f8ller","year":"2020","unstructured":"M\u00f8ller, P. R. et al. Recurrence of cholesteatoma: A retrospective study including 1,006 patients for more than 33 years. Int. Arch. Otorhinolaryngol. 24, e18\u2013e23 (2020).","journal-title":"Int. Arch. Otorhinolaryngol."},{"key":"34922_CR7","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1097\/MOO.0000000000000655","volume":"28","author":"T Yamamoto-Fukuda","year":"2020","unstructured":"Yamamoto-Fukuda, T. & Akiyama, N. Keratinocyte growth factor signaling promotes stem\/progenitor cell proliferation under p63 expression during middle ear cholesteatoma formation. Curr. Opin. Otolaryngol. Head Neck Surg. 28, 291\u2013295 (2020).","journal-title":"Curr. Opin. Otolaryngol. Head Neck Surg."},{"key":"34922_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijporl.2020.110545","volume":"140","author":"T Yamamoto-Fukuda","year":"2021","unstructured":"Yamamoto-Fukuda, T., Akiyama, N., Tatsumi, N., Okabe, M. & Kojima, H. Menin-MLL inhibitor blocks progression of middle ear cholesteatoma in vivo. Int. J. Pediatr. Otorhinolaryngol. 140, 110545 (2021).","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"key":"34922_CR9","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.cell.2007.02.009","volume":"128","author":"B Schuettengruber","year":"2007","unstructured":"Schuettengruber, B., Chourrout, D., Vervoort, M., Leblanc, B. & Cavalli, G. Genome regulation by polycomb and trithorax proteins. Cell 128, 735\u2013745 (2007).","journal-title":"Cell"},{"key":"34922_CR10","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nm.3830","volume":"21","author":"R Malik","year":"2015","unstructured":"Malik, R. et al. Targeting the MLL complex in castration-resistant prostate cancer. Nat. Med. 21, 344\u2013352 (2015).","journal-title":"Nat. Med."},{"key":"34922_CR11","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/j.kint.2019.06.021","volume":"96","author":"H Shimoda","year":"2019","unstructured":"Shimoda, H. et al. Inhibition of the H3K4 methyltransferase MLL1\/WDR5 complex attenuates renal senescence in ischemia-reperfusion mice by reduction of p16INK4a. Kidney Int. 96, 1162\u20131175 (2019).","journal-title":"Kidney Int."},{"key":"34922_CR12","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.stem.2008.11.011","volume":"4","author":"K Cui","year":"2009","unstructured":"Cui, K. et al. Chromatin signatures in multipotent human hematopoietic stem cells indicate the fate of bivalent genes during differentiation. Cell Stem Cell 4, 80\u201393 (2009).","journal-title":"Cell Stem Cell"},{"key":"34922_CR13","doi-asserted-by":"publisher","first-page":"9451","DOI":"10.1007\/s00432-023-04752-9","volume":"149","author":"WCM Dempke","year":"2023","unstructured":"Dempke, W. C. M., Desole, M., Chiusolo, P., Sica, S. & Schmidt-Hieber, M. Targeting the undruggable: Menin inhibitors ante portas. J. Cancer Res. Clin. Oncol. 149, 9451\u20139459 (2023).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"34922_CR14","doi-asserted-by":"publisher","first-page":"16195","DOI":"10.1038\/ncomms16195","volume":"9","author":"G Wu","year":"2018","unstructured":"Wu, G. et al. Menin enhances c-Myc-mediated transcription to promote cancer progression. Nat. Commun. 9, 16195 (2018).","journal-title":"Nat. Commun."},{"key":"34922_CR15","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1097\/01.mao.0000226290.04048.d9","volume":"27","author":"K Ozturk","year":"2006","unstructured":"Ozturk, K. et al. Evaluation of c-MYC status in primary acquired cholesteatoma by using fluorescence in situ hybridization technique. Otol. Neurotol. 27, 588\u2013591 (2006).","journal-title":"Otol. Neurotol."},{"key":"34922_CR16","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1039\/C7MD00170C","volume":"8","author":"W Jedwabny","year":"2017","unstructured":"Jedwabny, W. et al. Theoretical models of inhibitory activity for inhibitors of protein-protein interactions: Targeting menin\u2013mixed lineage leukemia with small molecules. MedChemComm 8, 2216\u20132227 (2017).","journal-title":"MedChemComm"},{"key":"34922_CR17","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.ccell.2015.02.016","volume":"27","author":"D Borkin","year":"2015","unstructured":"Borkin, D. et al. Pharmacologic inhibition of the menin-MLL interaction blocks progression of MLL leukemia in vivo. Cancer Cell 27, 589\u2013602 (2015).","journal-title":"Cancer Cell"},{"key":"34922_CR18","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.ccell.2019.11.001","volume":"36","author":"AV Krivtsov","year":"2019","unstructured":"Krivtsov, A. V. et al. A menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia. Cancer Cell 36, 660-673.e11 (2019).","journal-title":"Cancer Cell"},{"key":"34922_CR19","doi-asserted-by":"publisher","first-page":"9451","DOI":"10.1007\/s00432-023-04752-9","volume":"149","author":"WCM Dempke","year":"2023","unstructured":"Dempke, W. C. M. et al. Targeting the undruggable: Menin inhibitors ante portas. J. Cancer Res. Clin. Oncol. 149, 9451\u20139459 (2023).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"34922_CR20","doi-asserted-by":"publisher","first-page":"4532","DOI":"10.1038\/s41598-023-31246-y","volume":"13","author":"T Yamamoto-Fukuda","year":"2023","unstructured":"Yamamoto-Fukuda, T., Pinto, F., Pitt, K. & Senoo, M. Inhibition of TGF-\u03b2 signaling enables long-term proliferation of mouse primary epithelial stem\/progenitor cells of the tympanic membrane and the middle ear mucosa. Sci. Rep. 13, 4532 (2023).","journal-title":"Sci. Rep."},{"key":"34922_CR21","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1007\/s00405-014-3237-6","volume":"272","author":"T Yamamoto-Fukuda","year":"2014","unstructured":"Yamamoto-Fukuda, T. et al. In vivo over-expression of KGF mimics human middle ear cholesteatoma. Eur. Arch. Otorhinolaryngol. 272, 2689\u20132696 (2014).","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"34922_CR22","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/MAO.0000000000003795","volume":"44","author":"T Yamamoto-Fukuda","year":"2023","unstructured":"Yamamoto-Fukuda, T., Akiyama, N., Hirabayashi, M., Shimmura, H. & Kojima, H. Epigenetic regulation as a new therapeutic target for middle ear cholesteatoma. Otol. Neurotol. 44, 273\u2013280 (2023).","journal-title":"Otol. Neurotol."},{"key":"34922_CR23","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.tibs.2013.05.005","volume":"38","author":"S Matkar","year":"2013","unstructured":"Matkar, S., Thiel, A. & Hua, X. Menin: A scaffold protein that controls gene expression and cell signaling. Trends Biochem. Sci. 38, 394\u2013402 (2013).","journal-title":"Trends Biochem. Sci."},{"key":"34922_CR24","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1111\/jcmm.14897","volume":"24","author":"L Bi","year":"2020","unstructured":"Bi, L. et al. CPF impedes cell cycle re-entry of quiescent lung cancer cells through transcriptional suppression of FACT and c-MYC. J. Cell. Mol. Med. 24, 2229\u20132239 (2020).","journal-title":"J. Cell. Mol. Med."},{"key":"34922_CR25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s40487-024-00262-x","volume":"12","author":"X Thomas","year":"2024","unstructured":"Thomas, X. Small molecule menin inhibitors: Novel therapeutic agents targeting acute myeloid leukemia with KMT2A rearrangement or NPM1 mutation. Oncol. Ther. 12, 57\u201372 (2024).","journal-title":"Oncol. Ther."},{"key":"34922_CR26","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1080\/17501911.2025.2485019","volume":"17","author":"MR Brown","year":"2025","unstructured":"Brown, M. R. & Soto-Feliciano, Y. M. Menin: From molecular insights to clinical impact. Epigenomics 17, 489\u2013505 (2025).","journal-title":"Epigenomics"},{"key":"34922_CR27","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3390\/diseases13070227","volume":"13","author":"M Canichella","year":"2025","unstructured":"Canichella, M., Papayannidis, C., Mazzone, C. & de Fabritiis, P. Therapeutic implications of menin inhibitors in the treatment of acute leukemia: A critical review. Diseases 13, 227 (2025).","journal-title":"Diseases"},{"key":"34922_CR28","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/s41568-021-00367-9","volume":"21","author":"C Lourenco","year":"2021","unstructured":"Lourenco, C. et al. MYC protein interactors in gene transcription and cancer. Nat. Rev. Cancer 21, 579\u2013591 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"34922_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1005884","volume":"12","author":"MH Shin","year":"2016","unstructured":"Shin, M. H. et al. A RUNX2-mediated epigenetic regulation of the survival of p53 defective cancer cells. PLoS Genet. 12, e1005884 (2016).","journal-title":"PLoS Genet."},{"key":"34922_CR30","unstructured":"Yamamoto-Fukuda, T. & Akiyama, N. Therapeutic agent for cholesteatoma. WO Patent 2025110175 (2025)."},{"key":"34922_CR31","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1111\/j.1476-5381.2010.00873.x","volume":"160","author":"JC McGrath","year":"2010","unstructured":"McGrath, J. C., Drummond, G. B., McLachlan, E. M., Kilkenny, C. & Wainwright, C. L. Guidelines for reporting experiments involving animals: The ARRIVE guidelines. Br. J. Pharmacol. 160, 1573\u20131576 (2010).","journal-title":"Br. J. Pharmacol."},{"key":"34922_CR32","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1111\/j.1476-5381.2010.00872.x","volume":"160","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny, C., Browne, W., Cuthill, I. C., Emerson, M. & Altman, D. G. Animal research: Reporting in vivo experiments\u2014the ARRIVE guidelines. Br. J. Pharmacol. 160, 1577\u20131579 (2010).","journal-title":"Br. J. Pharmacol."},{"key":"34922_CR33","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.ajpath.2022.07.010","volume":"192","author":"T Yamamoto-Fukuda","year":"2022","unstructured":"Yamamoto-Fukuda, T. et al. Keratinocyte growth factor stimulates growth of p75+ neural crest lineage cells during middle ear cholesteatoma formation in mice. Am. J. Pathol. 192, 1573\u20131591 (2022).","journal-title":"Am. J. Pathol."},{"key":"34922_CR34","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1016\/j.ajpath.2020.04.007","volume":"190","author":"T Yamamoto-Fukuda","year":"2020","unstructured":"Yamamoto-Fukuda, T., Akiyama, N. & Kojima, H. L1CAM\u2013ILK\u2013YAP mechanotransduction drives proliferative activity of epithelial cells in middle ear cholesteatoma. Am. J. Pathol. 190, 1667\u20131679 (2020).","journal-title":"Am. J. Pathol."},{"key":"34922_CR35","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.anl.2025.09.006","volume":"52","author":"N Akiyama","year":"2025","unstructured":"Akiyama, N., Yamamoto-Fukuda, T. & Kojima, H. Effect of histone acetyltransferase inhibitor against middle ear cholesteatoma in a mouse model. Auris Nasus Larynx 52, 657\u2013663 (2025).","journal-title":"Auris Nasus Larynx"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34922-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34922-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34922-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T10:02:30Z","timestamp":1769421750000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34922-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,26]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["34922"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-34922-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,26]]},"assertion":[{"value":"8 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2539"}}